BLACKROCK MICROSYSTEMS, INC

BlackRock Microsystems, Inc. specializes in the design, development, and integration of advanced electromedical and electrophysiological systems, with a focused expertise in neural signal processing hardware and proprietary electrode arrays. The company delivers custom-engineered neuroport systems, including high-density EEG platforms with trade-in capabilities, and supports mission-critical applications through ruggedized, low-noise signal acquisition architectures. Their technical proficiency spans real-time neural data acquisition, implantable and wearable neurostimulation interfaces, and analytical instrumentation for clinical and research environments, positioning them as a niche provider of FDA-regulated medical devices for neurological monitoring and intervention. Differentiators include proprietary array fabrication techniques and closed-loop signal processing firmware tailored for low-power, high-fidelity neural data transmission. The company maintains a strong, recurring relationship with the Department of Veterans Affairs and the Department of Health and Human Services, delivering turnkey neural signal systems for veteran rehabilitation programs, neurodegenerative disease research, and clinical neurophysiology labs. Work with these agencies centers on procurement of integrated hardware-software platforms that support long-term patient monitoring and translational neuroscience studies. BlackRock Microsystems operates primarily within NAICS 334510, manufacturing electromedical apparatuses for diagnostic and therapeutic neuroapplications, and secondarily in 334516, producing precision analytical instruments for neuroscientific data collection. Their market positioning is defined by deep specialization in neurotechnology, serving government-funded biomedical research and clinical care delivery channels. As a small business entity structured as a 2L, BlackRock Microsystems is based in Salt Lake City, Utah, with no federal certifications on record. The company’s geographic footprint is concentrated in federal healthcare procurement corridors, leveraging its technical niche to serve mission-driven agencies requiring compliant, high-performance neuroengineering solutions.